What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed ...

What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

View the latest Bruker Corp. (BRKR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...

Key Insights Bruker's estimated fair value is US$48.33 based on 2 Stage Free Cash Flow to Equity Current share price ...

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

Bruker Corporation is a life-sciences company that has delivered returns of 20% annually for the last 15 years, comfortably beating the S&P 500. However, the share price has fallen -34% from its ...

Bruker expects to right-size PhenomeX’s cost structure immediately and expects the acquisition of PhenomeX to be slightly dilutive to Bruker’s non-GAAP EPS in 2024 and 2025, and accretive to ...

Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...

Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...

Bruker won the auction, held Tuesday, by increasing its earlier qualifying bid with a revised offer that was 78% above the $220 million offered by healthcare investment firm Patient Square Capital.